Here’s a **comprehensive, concise-but-complete medical reference on Asthma**, following the full clinical pattern you prefer 👇 --- ## 🫁 **ASTHMA — Complete Medical Overview** ### **1. Definition** Asthma is a **chronic inflammatory disorder of the airways** characterized by **reversible airflow obstruction** and **bronchial hyperresponsiveness** leading to recurrent episodes of wheezing, breathlessness, chest tightness, and cough — especially at night or early morning. --- ### **2. Pathophysiology** * **Airway inflammation** → infiltration by **eosinophils, mast cells, Th2 lymphocytes**. * **Bronchial hyperresponsiveness** → exaggerated airway narrowing to stimuli. * **Reversible airflow obstruction** due to: * Smooth muscle constriction * Mucosal edema * Mucus hypersecretion * **Remodeling** in chronic cases: thickened basement membrane, goblet cell hyperplasia, subepithelial fibrosis. --- ### **3. Etiology / Triggers** * **Genetic:** Atopy, family history of asthma/allergies. * **Environmental:** House dust mites, pollen, pet dander, molds. * **Infections:** Viral URTI (especially RSV, rhinovirus). * **Occupational exposures:** chemicals, dust, fumes. * **Drugs:** β-blockers, aspirin, NSAIDs. * **Other triggers:** cold air, exercise, emotions, air pollution, GERD, smoking. --- ### **4. Clinical Features** **Typical symptoms:** * Episodic wheezing, dyspnea, cough (esp. nocturnal), chest tightness. * Symptom variability and reversibility. **Signs:** * Prolonged expiration, widespread wheeze. * Severe attack: tachypnea, tachycardia, use of accessory muscles, pulsus paradoxus, silent chest (ominous). --- ### **5. Investigations / Diagnosis** 1. **Spirometry (Gold standard):** * FEV₁/FVC < 70% and **≥12% (or 200 mL)** improvement in FEV₁ post-bronchodilator → reversible. 2. **Peak Expiratory Flow Rate (PEFR):** diurnal variability > 20%. 3. **Methacholine challenge test:** for equivocal cases. 4. **Allergy testing:** skin prick / specific IgE. 5. **Chest X-ray:** often normal; hyperinflation possible. 6. **Blood:** eosinophilia, ↑IgE. --- ### **6. Differential Diagnoses** * COPD * Heart failure (“cardiac asthma”) * Vocal cord dysfunction * Bronchiectasis * Foreign body aspiration * GERD-related cough --- ### **7. Management** #### **A. Acute Exacerbation (Emergency)** **Assessment:** * Mild/moderate/severe/life-threatening based on PEF, RR, SpO₂. **Treatment (Stepwise):** 1. **O₂ therapy:** maintain SpO₂ > 94%. 2. **Short-acting β₂-agonist (SABA):** * *Salbutamol (albuterol)* 2.5 mg via nebulizer q20min ×3, then as needed. 3. **Anticholinergic:** * *Ipratropium bromide* nebulization with SABA in moderate–severe attacks. 4. **Systemic corticosteroids:** * *Prednisolone* 40–50 mg PO daily × 5 days (or IV hydrocortisone). 5. **If poor response:** * *IV magnesium sulfate* (2 g over 20 min). * Consider *IV aminophylline* or *IV salbutamol* (in ICU). 6. **Non-invasive ventilation / Intubation:** if impending respiratory failure. --- #### **B. Chronic (Long-term) Management** **Stepwise approach (GINA 2025 simplified):** | Step | Controller | Reliever | Indication | | ---- | ----------------------------------------------- | -------- | ------------------- | | 1 | Low-dose ICS-formoterol (as needed) | same | Infrequent symptoms | | 2 | Daily low-dose ICS or as-needed ICS-formoterol | same | Symptoms >2×/month | | 3 | Low-dose ICS-LABA | same | Symptoms most days | | 4 | Medium-dose ICS-LABA | same | Uncontrolled | | 5 | Add-on therapy (LAMA, biologics, oral steroids) | same | Severe asthma | **Add-on therapies:** * **LAMA:** Tiotropium. * **Biologics:** * *Omalizumab* (anti-IgE) — allergic asthma. * *Mepolizumab, Benralizumab* (anti–IL-5) — eosinophilic asthma. * *Dupilumab* (anti–IL-4Rα). **Non-pharmacologic:** * Trigger avoidance. * Smoking cessation. * Vaccination (Influenza, Pneumococcal). * Education: inhaler technique, adherence, written asthma action plan. --- ### **8. Drug Details** #### **Salbutamol (Albuterol)** * **Class:** Short-acting β₂-agonist (SABA). * **MOA:** Stimulates β₂ receptors → bronchodilation. * **Dose:** 100–200 mcg (1–2 puffs) q4–6h PRN; nebulizer 2.5 mg q20min ×3. * **Adverse effects:** Tremor, tachycardia, hypokalemia, palpitations. * **Contraindication:** Tachyarrhythmia. * **Interactions:** β-blockers antagonize effect. * **Monitor:** HR, potassium, symptom relief. * **Counsel:** Carry inhaler, avoid overuse. #### **Inhaled Corticosteroids (e.g., Budesonide, Fluticasone)** * **MOA:** ↓ airway inflammation, eosinophil activity, cytokine production. * **Dose:** Budesonide 200–400 µg BD. * **Adverse effects:** Oral thrush, dysphonia. * **Counsel:** Rinse mouth after use. #### **LABA (e.g., Formoterol, Salmeterol)** * **MOA:** Long-acting β₂ stimulation → bronchodilation. * **Use only with ICS** (never alone). * **Adverse:** Tachycardia, tremor. #### **Leukotriene receptor antagonist (Montelukast)** * **MOA:** Blocks CysLT₁ receptor → ↓ bronchoconstriction. * **Dose:** 10 mg HS. * **Adverse:** Headache, neuropsychiatric effects. #### **Omalizumab** * **MOA:** Anti-IgE monoclonal antibody → ↓ allergic response. * **Use:** Severe allergic asthma with high IgE. * **Route:** SC q2–4 weeks. * **Adverse:** Injection site reaction, anaphylaxis (rare). --- ### **9. Monitoring & Follow-Up** * Peak flow diary. * Asthma Control Test (ACT) every visit. * Review inhaler technique and adherence regularly. * Step up or down therapy every 3 months based on control. --- ### **10. Complications** * Status asthmaticus * Respiratory failure * Pneumothorax * Airway remodeling → fixed obstruction --- ### **11. Prognosis** * Excellent with control and adherence. * Severe uncontrolled asthma may lead to chronic airway changes and reduced quality of life. --- ### **12. Tags** asthma, bronchial asthma, airway obstruction, allergic asthma, eosinophilic inflammation, bronchodilator, corticosteroid, respiratory disease, omalizumab, formoterol, salbutamol, GINA guidelines, asthma management, emergency treatment, stepwise therapy, peak flow, spirometry, reversible obstruction --- Would you like me to now create **25 case-based MCQs on Asthma** (with explanations + interactive HTML/JS quiz format in one file)?Perfect 👍 — here’s a **complete, clinically structured “Asthma Rx (treatment)” guide for different case scenarios**, covering **acute, chronic, exercise-induced, aspirin-sensitive, nocturnal, occupational, and severe asthma** cases — with **precise regimen, dosing, rationale, and escalation plan** (Rx = prescription). --- ## 🫁 **ASTHMA — Rx for Different Case Scenarios** --- ### **1️⃣ Mild Intermittent Asthma** **Case:** 25-year-old with occasional wheeze (<2×/week), no nocturnal symptoms. **Rx:** * **As-needed low-dose ICS–formoterol** (preferred) or **Salbutamol MDI 100 µg**, 1–2 puffs as needed (max q4h). * **Non-pharmacologic:** trigger avoidance, smoking cessation, influenza vaccine. * **Follow-up:** reassess control after 3 months. --- ### **2️⃣ Mild Persistent Asthma** **Case:** Symptoms >2×/week but <daily; occasional night awakenings. **Rx:** * **Controller:** Low-dose inhaled corticosteroid (ICS) * *Budesonide 200 µg* BD or *Fluticasone 100 µg* BD. * **Reliever:** As-needed *ICS-formoterol* (preferred) or *Salbutamol*. * **Education:** daily controller adherence; check inhaler technique. * **Review:** Step-up if uncontrolled after 3 months. --- ### **3️⃣ Moderate Persistent Asthma** **Case:** Daily symptoms, night symptoms >1×/week, mild limitation of activity. **Rx:** * **Controller:** Low-dose ICS + LABA (fixed-dose combination). * *Budesonide–Formoterol 200/6 µg*, 1 puff BD. * **Reliever:** Same combination as needed (SMART approach). * **Adjunct:** Montelukast 10 mg HS if allergic/exercise-related. * **Review:** Step-up if still uncontrolled after 3 months. --- ### **4️⃣ Severe Persistent Asthma** **Case:** Symptoms continuous, frequent exacerbations, limited activity. **Rx:** * **Controller:** Medium/high-dose ICS + LABA. * *Budesonide–Formoterol 400/12 µg*, 2 puffs BD. * **Add-on:** * *Tiotropium 18 µg OD (LAMA)* via Respimat. * *Montelukast 10 mg HS*. * **If allergic phenotype:** *Omalizumab* 150–300 mg SC q2–4 weeks. * **If eosinophilic phenotype:** *Mepolizumab 100 mg SC q4 weeks* or *Benralizumab*. * **Reliever:** same ICS-formoterol or *SABA* PRN. * **If uncontrolled → short course oral steroid:** * *Prednisolone 40 mg OD × 5–7 days*. --- ### **5️⃣ Acute Exacerbation (Mild/Moderate)** **Case:** 30-year-old with acute dyspnea, PEF > 50%. **Rx:** 1. **O₂** to maintain SpO₂ > 94%. 2. **Nebulized Salbutamol 2.5 mg q20 min × 3**, then PRN. 3. **Add Ipratropium 0.5 mg** with each neb (if moderate). 4. **Oral Prednisolone 40 mg OD × 5 days**. 5. Continue regular ICS–LABA after recovery. 6. **Reassess PEF & symptoms** before discharge. --- ### **6️⃣ Acute Severe Asthma** **Case:** Speaking in phrases, RR > 30, HR > 120, PEF < 50%. **Rx (Emergency):** * **O₂:** target SpO₂ > 94%. * **Nebulized Salbutamol + Ipratropium q20 min for 1 h.** * **IV Hydrocortisone 100 mg q6h** (or Prednisolone PO if able). * **IV Magnesium Sulfate 2 g over 20 min** if poor response. * **If still poor:** *IV Aminophylline loading 5 mg/kg → infusion 0.5 mg/kg/h*. * **Monitor ABG, SpO₂, ECG.** * **Admit**; escalate to ICU if exhaustion, silent chest, or rising CO₂. --- ### **7️⃣ Life-Threatening Asthma** **Case:** Silent chest, cyanosis, confusion, PCO₂ > 45 mmHg. **Rx:** * **Immediate ICU transfer.** * **High-flow O₂**, **continuous nebulized bronchodilator**, **IV steroids**, **MgSO₄**, ± IV β₂-agonist. * **Intubation + mechanical ventilation** if impending arrest. --- ### **8️⃣ Exercise-Induced Asthma** **Case:** 17-year-old with wheeze after running, otherwise well. **Rx:** * **Pre-exercise:** * *Salbutamol 100–200 µg MDI* 15 min before activity, or * *Montelukast 10 mg* 2 h before exercise. * **If persistent:** regular low-dose ICS. * **Warm-up before exercise**, avoid cold air exposure. --- ### **9️⃣ Nocturnal Asthma** **Case:** 35-year-old with night wheeze and early morning cough. **Rx:** * **Controller:** Step-up ICS dose or ICS-LABA. * **Add Montelukast 10 mg HS.** * **Evaluate:** GERD, dust-mite exposure, β-blockers, postnasal drip. * **Lifestyle:** Elevate head of bed, avoid late meals. --- ### **🔟 Aspirin-Sensitive (Samter’s Triad) Asthma** **Case:** Adult with nasal polyps, asthma, and aspirin intolerance. **Rx:** * **Avoid all NSAIDs & aspirin.** * **Controller:** ICS–LABA. * **Add:** *Montelukast 10 mg HS* (very effective). * **Consider:** *Low-dose aspirin desensitization* under supervision if needed. * **ENT management:** nasal steroids, possible surgery for polyps. --- ### **11️⃣ Occupational Asthma** **Case:** 40-year-old factory worker with wheeze during workdays, better on weekends. **Rx:** * **Primary step:** remove exposure or job relocation. * **Pharmacologic:** standard ICS–LABA regimen. * **Add:** Montelukast 10 mg HS. * **Documentation:** occupational report for compensation. --- ### **12️⃣ Asthma in Pregnancy** **Case:** 28-year-old 2nd-trimester, mild asthma. **Rx:** * **Continue usual ICS–LABA** (safe). * **Preferred:** *Budesonide* as ICS, *Salbutamol* for rescue. * **Avoid:** Oral steroids unless severe. * **Monitor:** fetal well-being, maternal control. * **Vaccinate:** influenza. --- ### **13️⃣ Pediatric Asthma (6–11 yrs)** **Case:** 8-year-old with wheeze 3×/week. **Rx:** * **Low-dose ICS (Budesonide 100 µg BD)** via spacer. * **Reliever:** *Salbutamol 100 µg 1 puff PRN*. * **If frequent symptoms:** ICS + LABA or add Montelukast. * **Education:** spacer technique, parental supervision. --- ### **14️⃣ Elderly Asthma with COPD overlap** **Case:** 70-year-old smoker, chronic cough, FEV₁ reversible by 15%. **Rx:** * **ICS + LABA ± LAMA (triple therapy).** * **Vaccinate:** Influenza, Pneumococcal. * **Smoking cessation essential.** * **Monitor:** steroid side effects, bone density. --- ### **15️⃣ Steroid-Dependent / Refractory Asthma** **Case:** Chronic uncontrolled despite high-dose ICS-LABA. **Rx:** * **Add-on biologic:** * *Omalizumab* (IgE), *Mepolizumab/Benralizumab* (IL-5), *Dupilumab* (IL-4Rα). * **Taper oral steroids if possible.** * **Monitor:** eosinophil count, IgE, liver, and eye for side effects. --- ### **16️⃣ Asthma with GERD / Rhinosinusitis** **Case:** Cough and wheeze with heartburn. **Rx:** * **Add PPI:** *Omeprazole 20 mg OD*. * **ICS + LABA as per step.** * **Treat rhinitis:** *Fluticasone nasal spray 50 µg each nostril BD.* --- ### **17️⃣ Post-Viral Asthma Exacerbation** **Case:** Wheeze 1 week after flu infection. **Rx:** * **ICS-LABA continuation.** * **Short oral Prednisolone 40 mg OD × 5 days.** * **Salbutamol PRN.** * **Rest & hydration.** --- ### **18️⃣ Status Asthmaticus** **Case:** Severe unresponsive asthma >24 h despite therapy. **Rx:** * **ICU admission.** * **Continuous SABA neb**, **IV hydrocortisone 100 mg q6h**, * **IV MgSO₄**, **Aminophylline infusion**, **O₂**, * **Possible intubation with ketamine.** --- ### **19️⃣ Cough-Variant Asthma** **Case:** Chronic dry cough without wheeze, reversible on bronchodilator. **Rx:** * **Low-dose ICS (Budesonide 200 µg BD).** * **Salbutamol PRN.** * **Add Montelukast if allergic.** * **Reassess in 6 weeks.** --- ### **20️⃣ Asthma in Smokers** **Case:** 40-year-old with 15-pack-year history. **Rx:** * **ICS + LABA** (less steroid-responsive). * **Add LAMA if overlap with COPD.** * **Strong smoking cessation counseling (Nicotine patch 21 mg OD).** --- --- ✅ **Summary Table – Stepwise Controller Escalation** | Step | Preferred Controller | Reliever | Add-ons | | ---- | ----------------------------------- | ------------------ | -------------------------- | | 1 | Low-dose ICS-formoterol (as needed) | Same | — | | 2 | Daily low-dose ICS | ICS-formoterol PRN | — | | 3 | Low-dose ICS-LABA | Same | Montelukast | | 4 | Medium-dose ICS-LABA | Same | Tiotropium | | 5 | High-dose ICS-LABA ± biologic | Same | Omalizumab / IL-5 blockers | --- ### **Patient Education (all cases)** * Demonstrate inhaler/spacer technique. * Avoid triggers (smoke, dust, cold). * Adherence to maintenance therapy even when asymptomatic. * Use peak-flow meter; note early drop >20%. * Written asthma action plan. * Yearly influenza vaccination. --- Would you like me to now make this into a **responsive HTML + CSS + JS case-selector interface** (e.g., dropdown to select case → shows treatment plan dynamically)?